United Therapeutics (NASDAQ:UTHR) CEO Sells 9,500 Shares of Stock
MarketBeat
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of United Therapeutics stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $499.03, for a total transaction of $4,740,785.00. Following the completion of the sale, the chief executive officer owned 324,443 shares of the company's stock, valued at approximately $161,906,790.29. The trade was a 2.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
NASDAQ:UTHR